Positron Corporation has posted a new industry update, "Positron Announces Strontium Sale" Chicago, IL – December 7, 2012 (PRNewswire) – Positron Corporation (OTCBB:POSC) posts their first commercial sale and shipment of Active Pharmaceutical Ingredient (API) grade Strontium-82 to a North American pharmaceutical company. Manhattan Isotope Technology (MIT), LLC, a wholly owned subsidiary of Position Corporation, completed the processing, production and shipment of their API grade strontium-82, which was delivered this week. The API was produced from target material received from one of its foreign collaborators for target irradiation. You may view the latest post at: http://www.positron.com/press/post/positron-announces-strontium-sale You received this e-mail because you asked to be notified when new updates are posted.
Market Data 
Markets 
AI
